A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
暂无分享,去创建一个
Rohit Loomba | Tanya Wolfson | Elhamy Heba | John W Erdman | William D O'Brien | Aiguo Han | Claude B Sirlin | A. Gamst | W. O’Brien | C. Sirlin | T. Wolfson | M. André | M. Valasek | A. Han | E. Heba | J. Erdman | R. Loomba | Eduardo A C Costa | Anthony C Gamst | Michael P Andre | Grace Y Lin | Mark A Valasek | G. Lin | Jeremy S Paige | Gregory S Bernstein | Marilia Fereirra | G. Bernstein | E. Costa | J. Paige | Marilia Fereirra | Eduardo A Costa | Elhamy Heba
[1] T. Riley,et al. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. , 2014, World journal of gastroenterology.
[2] Q. Pan,et al. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[3] Arun J. Sanyal,et al. 非アルコール性脂肪肝炎の治療薬およびバイオマーカーの開発における課題と機会 : 米国肝臓病学会(American Association for the Study of Liver Diseases)と米国食品医薬品局の合同ワークショップの知見と推奨 , 2015 .
[4] S. Ahn,et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[5] A. Gamst,et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. , 2015, Radiology.
[6] A. Gamst,et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. , 2013, Radiology.
[7] P. Hayes,et al. The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. , 2011, Clinical radiology.
[8] Rohit Loomba,et al. The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.
[9] Nik Raihan Nik Mustapha,et al. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease , 2014, Journal of gastroenterology and hepatology.
[10] L Dalla Palma,et al. Noninvasive in vivo quantitative assessment of fat content in human liver. , 1997, Journal of hepatology.
[11] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[12] Anthony Gamst,et al. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[13] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[14] L. X. Yao,et al. Backscatter Coefficient Measurements Using a Reference Phantom to Extract Depth-Dependent Instrumentation Factors , 1990, Ultrasonic imaging.
[15] A. Lonardo,et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[16] H. Ermert,et al. An ultrasound research interface for a clinical system , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[17] J. Stoker,et al. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis , 2010, European Radiology.
[18] S. Mudaliar,et al. Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes , 2011, Diabetes, obesity & metabolism.
[19] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[20] Chris Day,et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.
[21] M. Kumar,et al. Controlled attenuation parameter for non‐invasive assessment of hepatic steatosis: Does etiology affect performance? , 2013, Journal of gastroenterology and hepatology.
[22] C. Sirlin,et al. In vivo characterization of the liver fat 1H MR spectrum , 2011, NMR in biomedicine.
[23] B. Choi,et al. Appropriateness of a donor liver with respect to macrosteatosis: application of artificial neural networks to US images--initial experience. , 2005, Radiology.
[24] L. Katsnelson,et al. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. , 2007, AJR. American journal of roentgenology.
[25] A. McCullough,et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. , 2009, Journal of hepatology.
[26] S. Horgan,et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. , 2011, Radiology.